Congressional Drug-Pricing Reforms Upend Trump’s Strategy
He has typically allied with Big Pharma, pointing fingers at pharmacy benefit managers. But a bipartisan agreement could do away with that gambit.
Read Full Article »
Comment
Show comments
Hide Comments
